U.S. FDA approves Biocon’s insulin Semglee

Biocon Biologics and Viatris Inc said the U.S. Food and Drug Administration (FDA) had approved Semglee®, a long-acting insulin injection, as the first

from The Hindu - Business https://ift.tt/3BXsXDR
via IFTTT